Your browser doesn't support javascript.
loading
Aurora-A inhibition offers a novel therapy effective against intracranial glioblastoma.
Van Brocklyn, James R; Wojton, Jeffrey; Meisen, Walter H; Kellough, David A; Ecsedy, Jeffery A; Kaur, Balveen; Lehman, Norman L.
Affiliation
  • Van Brocklyn JR; Department of Pathology, The Ohio State University, Columbus Ohio.
  • Wojton J; Department of Neurosurgery, The Ohio State University, Columbus Ohio.
  • Meisen WH; Department of Neurosurgery, The Ohio State University, Columbus Ohio.
  • Kellough DA; Department of Pathology, The Ohio State University, Columbus Ohio.
  • Ecsedy JA; Oncology Translational Medicine, Takeda Pharmaceuticals International Co., Cambridge, Massachusetts.
  • Kaur B; Department of Neurosurgery, The Ohio State University, Columbus Ohio. Department of Neuroscience, The Ohio State University, Columbus Ohio.
  • Lehman NL; Department of Pathology, The Ohio State University, Columbus Ohio. Department of Neuroscience, The Ohio State University, Columbus Ohio. nllehman@yahoo.com.
Cancer Res ; 74(19): 5364-70, 2014 Oct 01.
Article in En | MEDLINE | ID: mdl-25106428
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Brain Neoplasms / Glioblastoma / Protein Kinase Inhibitors / Aurora Kinase A Limits: Animals / Female / Humans Language: En Journal: Cancer Res Year: 2014 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Brain Neoplasms / Glioblastoma / Protein Kinase Inhibitors / Aurora Kinase A Limits: Animals / Female / Humans Language: En Journal: Cancer Res Year: 2014 Document type: Article